title: IL-2 immunotherapy-induced increase in IL-12 blood concentrations may depend on an increase in circulating dendritic cell number.
authors.forename: P
authors.initials: P
authors.lastname: Lissoni
authors.forename: R
authors.initials: R
authors.lastname: Bucovec
authors.forename: S
authors.initials: S
authors.lastname: Meregalli
authors.forename: L
authors.initials: L
authors.lastname: Fumagalli
authors.forename: L
authors.initials: L
authors.lastname: Vigorè
authors.forename: R
authors.initials: R
authors.lastname: Ferrante
authors.forename: F
authors.initials: F
authors.lastname: Brivio
mesh_terms: D000368:Aged; D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000628:therapy*; D002452:Cell Count; D003713:Dendritic Cells / Q000502:physiology*; D005260:Female; D006801:Humans; D018664:Interleukin-12 / Q000097:blood*; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000276:immunology / Q000628:therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D007376:Interleukin-2; D018664:Interleukin-12